Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital — Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.
from Techmeme https://ift.tt/36VrWeR
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)
![Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)]()
Reviewed by swadu
on
February 04, 2020
Rating:
No comments: